<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04652336</url>
  </required_header>
  <id_info>
    <org_study_id>GHC-16-OCT/2020</org_study_id>
    <nct_id>NCT04652336</nct_id>
  </id_info>
  <brief_title>Study Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG</brief_title>
  <official_title>Randomized Controlled Trial Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GEM Hospital &amp; Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GEM Hospital &amp; Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effect of ligamentum teres cardiopexy on&#xD;
      incidence of de Novo GERD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopic Sleeve Gastrectomy (LSG) is now the most commonly performed bariatric surgery&#xD;
      world wide. The results of LSG on outcomes of GERD are conflicting. It has been reported to&#xD;
      increase the severity of pre existing GERD and also to cause new onset GERD in considerable&#xD;
      number of patients.&#xD;
&#xD;
      In this study the effect of adding a novel procedure i.e. ligamentum teres cardiopexy,(LTC)&#xD;
      to regular LSG on occurence of de Novo GERD will be investigated. de Novo GERD has been found&#xD;
      to occur in 20% of cases post LSG.&#xD;
&#xD;
      This study is a randomized, prospective, parallel group, controlled trial to compare the&#xD;
      effect of LSG versus LSG with LTC on occurence of de Novo GERD.&#xD;
&#xD;
      This is a single center based trial, being conducted in GEM hospital and research center,&#xD;
      Coimbatore, Tamil Nadu, India. The trial has been approved by GEM research ethics committee.&#xD;
&#xD;
      Investigators are planning to enroll patients who are not having any objective or subjective&#xD;
      evidence of GERD. The participants will be optimized as per institutional bariatric surgery&#xD;
      protocol. After complete evaluation and optimization, participants will be randomized by&#xD;
      computer generated random numbers into either LSG or LSG with LTC group.&#xD;
&#xD;
      The demographic data, preoperative GERD - Q scores, 24 hour pH study, intra operative details&#xD;
      will be recorded. Post operative details during each follow up will be recorded, which will&#xD;
      include excess weight loss, GERD - Q scores. At 6 months follow up repeat 24 hour pH study&#xD;
      will be done to assess the status of GERD objectively.&#xD;
&#xD;
      The trial duration is expected to be of 1 year where in investigators will be recruiting&#xD;
      patients for 6 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 10, 2020</start_date>
  <completion_date type="Anticipated">December 10, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>GERD</measure>
    <time_frame>6 months</time_frame>
    <description>Subjective (Gastroesophageal Reflux Disease questionnaires - GERD - Q) and objective (24 hour pH study) measurement of occurence of GERD will be done GERD - Q - Score 0-2 denotes no GERD. Score more than or equal to 3 indicates presence of GERD 24 hr pH study - Demeester score more than 14.7 is indicative of presence of GERD</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>GERD</condition>
  <arm_group>
    <arm_group_label>LSG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive standard laparoscopic sleeve gastrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSG with LTC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive LSG along with the novel LTC procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic sleeve gastrectomy</intervention_name>
    <description>Comparator arm - will receive standard laparoscopic sleeve gastrectomy</description>
    <arm_group_label>LSG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ligamentum teres cardiopexy with sleeve gastrectomy</intervention_name>
    <description>experimental arm - Ligamentum teres will be divided from umbilicus to up to umbilical fissure. The ligament will then be wrapped around lower esophagus and sutured.</description>
    <arm_group_label>LSG with LTC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  candidate for bariatric surgery according to IFSO - APC guidelines&#xD;
&#xD;
          -  No evidence (objective and subjective) of GERD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of GERD either by history or by 24 hr pH study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>PRAKHAR GUPTA</last_name>
    <phone>+919582438389</phone>
    <email>mailto.guptaprakhar@gmail.com</email>
  </overall_contact>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 26, 2020</study_first_submitted>
  <study_first_submitted_qc>November 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>December 17, 2020</last_update_submitted>
  <last_update_submitted_qc>December 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>de Novo GERD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

